Research Studies
Leaders in Ophthalmic Clinical Research
Connecticut Eye Consultants, P.C. has been participating in clinical trials for more than 30 years. Our research department employs a full-time, certified research coordinator and ancillary staff dedicated entirely to clinical trials.
The CEC research department has conducted Phase II, III, and IIIb clinical trials as well as post-marketing studies on treatments for a variety of eye diseases. Our trials have been sponsored by Alcon, Allergan, Astra Zeneca, Bausch and Lomb, CIBA Vision Corp., INSite vision, ISTA Pharmaceuticals, Merck, Pharmacia Corporation, Inspire Pharmaceuticals, Genentech, Genera, Pfizer, and Sirion Therapeutics. We are the only center in western Connecticut for the Diabetic Retinopathy Clinical Research Network (DRCR.net), a part of the National Eye Institute/National Institutes of Health.
Ophthalmology clinical trials can vary in duration from five days to three years, depending on the disease or indication being studied. Common indications include dry eyes, glaucoma, conjunctivitis, macular degeneration, cataract surgery, vision correction surgery, and various retinal diseases. Some trials offer participant compensation for time and travel. The primary concern of any clinical trial is the patient’s health, safety, and welfare. All study visits are conducted by one or more of the physicians at Connecticut Eye Consultants. Participation in clinical trials provides patients with the opportunity to have access to new medications or treatments that may improve their quality of life and impact the lives of patients in the future.
Please click here to see the research studies in which we are currently enrolling patients. For more information about any of these trials, please contact our research coordinator, Angela Smit, at clinicaleye@danburyeye.com or (203) 791-2020 ext. 256.
